Published in Circulation on January 01, 1991
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart (2005) 9.79
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet (2008) 8.73
Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med (2013) 7.30
Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ (2003) 4.74
Management of raised blood pressure in New Zealand: a discussion document. BMJ (1993) 3.96
Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study. BMJ (2011) 3.86
How good is the Prevent model for estimating the health benefits of prevention? J Epidemiol Community Health (1999) 3.82
The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study. Br J Gen Pract (2005) 3.65
Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study. BMJ (1995) 3.40
A simple computer program for guiding management of cardiovascular risk factors and prescribing. BMJ (1999) 3.23
Coronary heart disease prevention: insights from modelling incremental cost effectiveness. BMJ (2003) 2.97
A general practice-based study examining the absolute risk of cardiovascular disease in treated hypertensive patients. Br J Gen Pract (1996) 2.94
Relationship of distance run per week to coronary heart disease risk factors in 8283 male runners. The National Runners' Health Study. Arch Intern Med (1997) 2.93
Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ (2016) 2.81
What is the optimal age for starting lipid lowering treatment? A mathematical model. BMJ (2000) 2.65
Revisiting Rose: strategies for reducing coronary heart disease. BMJ (2006) 2.53
Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial. Br J Gen Pract (2010) 2.42
The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited) -- a prospective population-based study. J Am Coll Cardiol (2013) 2.36
Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. Br J Gen Pract (2010) 2.32
Primary prevention of heart disease and stroke: a simplified approach to estimating risk of events and making drug treatment decisions. CMAJ (1997) 2.30
Thresholds in the relationship between mortality and left ventricular hypertrophy defined by electrocardiography. J Electrocardiol (2008) 2.29
Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC Cardiovasc Disord (2007) 2.24
High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum (2008) 2.14
Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart (2000) 2.05
Guidelines for managing raised blood pressure. BMJ (1996) 2.03
Using the Framingham model to predict heart disease in the United Kingdom: retrospective study. BMJ (2000) 2.02
Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function? Heart (2002) 1.98
Using additional information on working hours to predict coronary heart disease: a cohort study. Ann Intern Med (2011) 1.93
Patients' perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies. Ann Fam Med (2006) 1.84
Treatment intensification and risk factor control: toward more clinically relevant quality measures. Med Care (2009) 1.79
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther (2011) 1.68
Clustering of risk factors and social class in childhood and adulthood in British women's heart and health study: cross sectional analysis. BMJ (2004) 1.66
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2009) 1.64
Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag (2009) 1.59
Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals. Atherosclerosis (2008) 1.58
Calibrating parametric subject-specific risk estimation. Biometrika (2010) 1.54
SCORE performance in Central and Eastern Europe and former Soviet Union: MONICA and HAPIEE results. Eur Heart J (2013) 1.50
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2007) 1.49
Ethnic Differences in Associations Between Blood Pressure and Stroke in South Asian and European Men. Hypertension (2015) 1.46
Relation of obstructive sleep apnea to coronary artery calcium in non-obese versus obese men and women aged 45-75 years. Am J Cardiol (2014) 1.45
Low prevalence of lipid lowering drug use in older men with established coronary heart disease. Heart (2002) 1.44
Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study. Diabetes Care (2009) 1.43
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I). Circulation (2016) 1.43
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2006) 1.42
Increasing overall physical activity and aerobic fitness is associated with improvements in metabolic risk: cohort analysis of the ProActive trial. Diabetologia (2008) 1.39
Cerebral cortical hyperactivation in response to mental stress in patients with coronary artery disease. Proc Natl Acad Sci U S A (1998) 1.38
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk. PLoS One (2011) 1.34
A review of neuroimaging studies of stressor-evoked blood pressure reactivity: emerging evidence for a brain-body pathway to coronary heart disease risk. Neuroimage (2009) 1.33
Rational Prescribing in Primary Care (RaPP-trial). A randomised trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs in general practice [ISRCTN48751230]. BMC Health Serv Res (2003) 1.32
The effect of alternative summary statistics for communicating risk reduction on decisions about taking statins: a randomized trial. PLoS Med (2009) 1.29
Journey in guidelines for lipid management: From adult treatment panel (ATP)-I to ATP-III and what to expect in ATP-IV. Indian J Endocrinol Metab (2013) 1.28
Comparison of methods to identify individuals at increased risk of coronary disease from the general population. BMJ (2003) 1.28
The use of cardiovascular risk factor information in practice databases: making the best of patient data. Br J Gen Pract (2006) 1.26
Estimating cardiovascular risk for primary prevention: outstanding questions for primary care. BMJ (2000) 1.24
A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT). J Epidemiol Community Health (2010) 1.22
Primary prevention of coronary heart disease. BMJ (2002) 1.21
Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores. J Epidemiol Community Health (1997) 1.21
The influence of hip circumference on the relationship between abdominal obesity and mortality. Int J Epidemiol (2012) 1.21
Cardiovascular risk scores do not account for the effect of treatment: a review. Heart (2011) 1.19
Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort. AIDS (2014) 1.19
A coronary heart disease risk score based on patient-reported information. Am J Cardiol (2007) 1.19
Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort. Clin Infect Dis (2011) 1.18
The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe. Curr Cardiovasc Risk Rep (2011) 1.17
The Framingham Heart Study's impact on global risk assessment. Prog Cardiovasc Dis (2010) 1.16
Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study. AIDS Care (2011) 1.13
Cardiovascular risk management of hypertension and hypercholesterolaemia in the Netherlands: from unifactorial to multifactorial approach. Neth Heart J (2012) 1.13
Adding monounsaturated fatty acids to a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. CMAJ (2010) 1.12
The role of global risk assessment in hypertension therapy. Can J Cardiol (2006) 1.12
Incidence of coronary artery disease in siblings of patients with premature coronary artery disease: 10 years of follow-up. Am J Cardiol (2007) 1.11
Development and validation of a coronary risk prediction model for older U.S. and European persons in the Cardiovascular Health Study and the Rotterdam Study. Ann Intern Med (2012) 1.10
Cardiovascular risk estimation in 2012: lessons learned and applicability to the HIV population. J Infect Dis (2012) 1.09
What is the best strategy for reducing deaths from heart disease? PLoS Med (2005) 1.07
Distribution of 10-year and lifetime predicted risk for cardiovascular disease in the Indian Sentinel Surveillance Study population (cross-sectional survey results). BMJ Open (2011) 1.07
Assessment of cardiovascular disease risk in South asian populations. Int J Vasc Med (2013) 1.07
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2010) 1.07
Prediction of cardiovascular death in racial/ethnic minorities using Framingham risk factors. Circ Cardiovasc Qual Outcomes (2010) 1.07
Combining information from multiple data sources to create multivariable risk models: illustration and preliminary assessment of a new method. J Biomed Biotechnol (2005) 1.05
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2008) 1.05
Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how? Hum Genet (2009) 1.03
Impact of chronic kidney disease on the severity of initially diagnosed coronary artery disease and the patient prognosis in the Japanese population. Heart Vessels (2010) 1.02
Prevalence, awareness, treatment, and control of high LDL cholesterol in New York City, 2004. Prev Chronic Dis (2010) 1.01
Lipid screening to prevent coronary artery disease: a quantitative evaluation of evolving guidelines. CMAJ (2000) 1.01
Replicability and 40-year predictive power of childhood ARC types. J Pers Soc Psychol (2011) 1.01
Impact of provision of cardiovascular disease risk estimates to healthcare professionals and patients: a systematic review. BMJ Open (2015) 1.01
Hypertension: reflections on risks and prognostication. Med Clin North Am (2009) 1.00
Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country--the case of Tanzania. Cost Eff Resour Alloc (2007) 0.99
Cardiovascular Disease Risk Assessment: Insights from Framingham. Glob Heart (2013) 0.98
Prediction of coronary artery disease by a systemic atherosclerosis score index derived from whole-body MR angiography. J Cardiovasc Magn Reson (2009) 0.97
Excess pressure integral predicts cardiovascular events independent of other risk factors in the conduit artery functional evaluation substudy of Anglo-Scandinavian Cardiac Outcomes Trial. Hypertension (2014) 0.97
The role of guidelines and the patient's life-style in GPs' management of hypercholesterolaemia. BMC Fam Pract (2004) 0.96
Which population groups should be targeted for cardiovascular prevention? A modelling study based on the Norwegian Hordaland Health Study (HUSK). Scand J Prim Health Care (2007) 0.96
Association of serum 25-hydroxyvitamin D with lifestyle factors and metabolic and cardiovascular disease markers: population-based cross-sectional study (FIN-D2D). PLoS One (2014) 0.95
Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study. Lipids Health Dis (2010) 0.95
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med (1990) 17.52
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Diabetes and cardiovascular disease. The Framingham study. JAMA (1979) 11.95
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
The Framingham Offspring Study. Design and preliminary data. Prev Med (1975) 10.53
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med (1982) 8.62
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09
The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med (1971) 7.46
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA (1986) 7.23
Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med (1990) 7.00
Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
STATISTICAL METHODS AND CONTROL IN BACTERIOLOGY. Bacteriol Rev (1943) 6.32
The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med (1999) 6.22
Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J (1986) 5.89
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
BIOLOGICAL DETERMINATION OF VITAMIN B1 (THIAMIN) IN RHIZOBIUM TRIFOLII. Science (1938) 5.59
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes (1974) 5.55
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37
Diabetes and cardiovascular risk factors: the Framingham study. Circulation (1979) 5.32
Mechanism of Biological Nitrogen Fixation: VI. Inhibition of Azotobacter by Hydrogen. Proc Natl Acad Sci U S A (1941) 5.23
Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA (1993) 5.21
Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol (1974) 5.11
Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11
A general cardiovascular risk profile: the Framingham Study. Am J Cardiol (1976) 5.10
Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol (1972) 5.05
Formation of the nitrogen-fixing enzyme system in Azotobacter vinelandii. Can J Microbiol (1968) 5.05
Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med (1984) 5.02
Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med (1979) 4.94
Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol (1971) 4.90
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med (1994) 4.74
Some health benefits of physical activity. The Framingham Study. Arch Intern Med (1979) 4.63
Mechanism of biological nitrogen fixation: Molecular H(2) and the pN(2) function of azotobacter. Biochem J (1941) 4.45
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
The epidemiology of gallbladder disease: observations in the Framingham Study. J Chronic Dis (1966) 4.15
Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J (1987) 4.12
Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med (1970) 4.11
The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med (1993) 4.04
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med (1990) 3.99
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis (2000) 3.81
Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr (2001) 3.80
Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79
Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care (1980) 3.70
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA (1996) 3.68
Variability of body weight and health outcomes in the Framingham population. N Engl J Med (1991) 3.61
Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J (2000) 3.61
Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes (2000) 3.60
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med (1976) 3.50
The Relationship Between Photosynthesis and Nitrogen Fixation. Proc Natl Acad Sci U S A (1952) 3.47
Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? JAMA (1993) 3.42
NITROGEN FIXATION BY PHOTOSYNTHETIC BACTERIA. J Bacteriol (1949) 3.33
Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation (1990) 3.29
INFLUENCE OF POTASSIUM NITRATE ON NODULE FORMATION AND NITROGEN FIXATION BY CLOVER. Plant Physiol (1932) 3.23
Premature mortality from coronary heart disease. The Framingham study. JAMA (1971) 3.15
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis (1998) 3.09
Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res (2000) 3.09
Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr (1994) 3.08
The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med (1967) 3.05
Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med (1987) 3.00
ENZYME LOCALIZATION IN Azotobacter Vinelandii. Proc Natl Acad Sci U S A (1955) 2.97
Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int (1999) 2.95
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA (1981) 2.93
Improved cloning vectors and transformation procedure for Lactococcus lactis. J Appl Bacteriol (1993) 2.91
Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med (1972) 2.91
Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med (1969) 2.88
The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease. Am J Epidemiol (1980) 2.86
Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med (1987) 2.82
Profile for estimating risk of heart failure. Arch Intern Med (1999) 2.81
Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. Lancet (1974) 2.81
Labile hypertension: a faulty concept? The Framingham study. Circulation (1980) 2.76
Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation (1975) 2.74
Hearing in the elderly: the Framingham cohort, 1983-1985. Part I. Basic audiometric test results. Ear Hear (1990) 2.71
Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med (1985) 2.71
Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke (2001) 2.71
Clustering of metabolic factors and coronary heart disease. Arch Intern Med (1999) 2.69
Ammonia as an Intermediate in Nitrogen Fixation by Azotobacter. J Bacteriol (1946) 2.68
Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA (1988) 2.68
Menopause and coronary heart disease. The Framingham Study. Ann Intern Med (1978) 2.62
Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med (1988) 2.62
Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 2.60
The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. JAMA (1988) 2.59